Peak Bio, Inc. announced that it has entered into a forward purchase agreement to issue common shares at a purchase price of $10 per share for the aggregate gross proceeds of $10,000,000 on April 7, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0086 USD | -.--% | -.--% | -95.41% |
Mar. 05 | Akari Therapeutics, Plc entered into a definitive agreement to acquire Peak Bio, Inc.. | CI |
Feb. 16 | Peak Bio, Inc. announced that it has received $2.238 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-95.41% | 199K | |
+52.15% | 55.7B | |
+41.08% | 39.91B | |
-5.91% | 39.57B | |
-5.56% | 28.16B | |
+16.16% | 26.3B | |
-19.81% | 18.94B | |
+32.03% | 12.17B | |
+26.55% | 12.12B | |
+1.46% | 12.12B |
- Stock Market
- Equities
- PKBO Stock
- News Peak Bio, Inc.
- Peak Bio, Inc. announced that it expects to receive $10 million in funding